ALIXANDRA ROBINSON: Open Payments
NPI 1417788217 · EL CENTRO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$246 in 11 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $87 · 2025 $246
Food & beverage: $246
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $73 |
| Galderma Laboratories, L.P. | 2 | $38 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| Hologic Sales and Service, LLC | 1 | $24 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $22 |
| Boston Scientific Corporation | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
Products named: BOTOX, XIFAXAN, GEMTESA, APTIMA, ISTURISA, WaveWriter Alpha Prime 16, Kerendia.
Industry payments across CA — which companies pay providers there.
